Human Hypertension Kidney Fibroblasts
Quick Actions
Product Overview
Description
Human Hypertension Kidney Fibroblasts, specifically myofibroblasts, are now defined not only by their role in causing fibrotic damage but also by their previously unrecognized function as genetic regulators of blood pressure.
Guarantee expansion for a minimum of 2-5 population
doublings.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBPH016
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characterization Markers
Cells test positive for the fibroblast-specific marker CD90 . They are negative for von Willebrand Factor (Factor VIII), cytokeratin 18, and alpha-smooth muscle actin, confirming the absence of endothelial, epithelial, and smooth muscle cells.
Quick Facts
Product Type
Human Hypertension Fibroblasts Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
